The Indoleamine 2,3-Dioxygenase (IDO) Pathway Is Constitutively Activated in HPV-Mediated Oropharyngeal Carcinoma

被引：0
|
作者：
Xu, J. [1 ]
Isayeva, T. [1 ]
Saag, M. [1 ]
Brandwein-Gensler, M. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1316
引用
收藏
页码：315A / 315A
页数：1
相关论文
共 50 条
  • [1] The Indoleamine 2,3-Dioxygenase (IDO) Pathway Is Constitutively Activated in HPV-Mediated Oropharyngeal Carcinoma
    Xu, J.
    Isayeva, T.
    Saag, M.
    Brandwein-Gensler, M.
    LABORATORY INVESTIGATION, 2013, 93 : 315A - 315A
  • [2] The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
    von Bubnoff, D.
    Bieber, T.
    ALLERGY, 2012, 67 (06) : 718 - 725
  • [3] Synthesis of indoleamine 2,3-dioxygenase (IDO) inhibitor
    Suzuki, Takafumi
    Yokoyama, Yuuaku
    Tsutumi, Katsuhiko
    Yamaguchi, Tomoyuki
    Takikawa, Osamu
    Okuno, Hiroaki
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 62 (01) : 114 - 115
  • [4] Neuroinflammation and Depression: The Role of Indoleamine 2,3-dioxygenase (IDO) as a Molecular Pathway
    Sublette, M. Elizabeth
    Postolache, Teodor T.
    PSYCHOSOMATIC MEDICINE, 2012, 74 (07): : 668 - 672
  • [5] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [6] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [7] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [8] Indoleamine 2,3-Dioxygenase (Ido) As A New Immunological Marker In Kidney
    Loiacono, Elisa
    Votta, Barbara
    Amore, Alessandro
    Peruzzi, Licia
    Puccinelli, Maria Paola
    Camilla, Roberta
    Vergano, Luca
    Guido, Giuliana
    Donadi, Maria Elena
    Coppo, Rosanna
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1525 - 1526
  • [9] Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination
    Macagno, M.
    Bolli, E.
    Marchini, C.
    Amici, A.
    Riganti, C.
    Bosia, A.
    Forni, G.
    Cavallo, F.
    EJC SUPPLEMENTS, 2010, 8 (05): : 75 - 75
  • [10] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
12345